Martinez, N. R., Augstein, P., Moustakas, A. K., Papadopoulos, G. K., Gregori, S., Adorini, L., . . . Harrison, L. C. (2003). Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. American Society for Clinical Investigation.
Citação norma ChicagoMartinez, Nathan R., Petra Augstein, Antonis K. Moustakas, George K. Papadopoulos, Silvia Gregori, Luciano Adorini, David C. Jackson, and Leonard C. Harrison. Disabling an Integral CTL Epitope Allows Suppression of Autoimmune Diabetes By Intranasal Proinsulin Peptide. American Society for Clinical Investigation, 2003.
MLA citiranjeMartinez, Nathan R., et al. Disabling an Integral CTL Epitope Allows Suppression of Autoimmune Diabetes By Intranasal Proinsulin Peptide. American Society for Clinical Investigation, 2003.